Andrew Marshall, Ph.D.

Dr Marshall is Chief Technology Officer of Healionics Corporation. As co-inventor of the STAR® material, he has over 15 years of experience working directly with this technology for improving biocompatibility, bio-integration and performance of implantable medical devices.

Find out more:

Dr Marshall has been recognized as one of the “Under 40 influential leaders and innovators” by Medical Devices & Diagnostics Industry magazine, and he was honoured at the 2012 World Congress on Tissue Engineering & Regenerative Medicine as the recipient of the Innovation/ Commercialisation Award. He holds 25 issued and pending patents.

Dr Marshall earned a Ph.D. in Chemical Engineering from the University of Washington and a BSE in Biomechanical Engineering from Stanford University.